Description
Uses of Medicine:
Palbociclib 125 mg, 100 mg, and 75 mg Tablets/Capsules fall under the group of anticancer medicines known as cyclin-dependent kinase inhibitors. This kinase inhibitor is supplied generically as well as in branded medicine. Patients, Healthcare Professionals (HCPs), or Hospitals can buy Palbociclib 125 mg, 100 mg, and 75 mg Tablets/Capsules online from India through THE INDIAN PHARMA (a trusted Palbociclib Supplier, Exporter, and Contract Manufacturer in India) for the management and treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with:- an aromatase inhibitor as initial endocrine-based therapy; or
- fulvestrant in patients with disease progression following endocrine therapy.
Palbociclib 125 mg, 100 mg, and 75 mg is a widely used medication for the treatment of HR-positive, HER2-negative advanced or metastatic breast cancer. This condition develops when unhealthy cells progress uncontrollably and reach other areas in the body. Palbociclib 125 mg, 100 mg, and 75 mg is used along with other anticancer medicines. This slows down the advancement of disease by inhibiting proteins responsible for cell division. By blocking cyclin-dependent kinases (CDK4/6), this oral drug helps to control tumor growth and increases the effectiveness of other treatments. As an oral medicine, it offers a suitable therapeutic option for those fighting advanced breast cancer.
Like most anticancer medicines, Palbociclib 125 mg, 100 mg, and 75 mg may cause some side effects. Some patients may experience low blood cell counts, which may lead to a higher risk of infections, swelling of the lips and mouth, dry eyes, taste changes, blurred vision, and excessive tearing. Although these effects can be readily managed. It is important to report any persistent or severe symptoms to your healthcare provider (HCP). Serious side effects, such as lung inflammation, can present as a dry cough, chest pain, or difficulty breathing. This may require immediate medical attention. Regular blood tests are often required to monitor blood cell levels and overall health throughout the treatment.
Before starting treatment with Palbociclib 125 mg, 100 mg, and 75 mg, it is important to let your healthcare provider know about any existing allergies, infections, liver or kidney disorders, or intolerance to certain sugars. This oral medicine is not suitable for children and adolescents aged under 18 and should be used with suitable contraception during treatment and for at least 3 weeks after the final dose, as it may harm an unborn child. Additionally, patients should disclose all medicines, including herbal supplements and over-the-counter drugs, to avoid potential interactions. Following prescribed guidelines and maintaining open communication with your healthcare provider (HCP) can help in managing side effects and improving treatment outcomes. Always seek professional medical advice to ensure safe and effective use of Palbociclib 125 mg, 100 mg, and 75 mg in your cancer treatment plan.
Dosage & Side Effects:
The recommended dose of Palbociclib is a 125 mg tablet/capsule taken orally once daily for 21 consecutive days followed by 7 days off treatment to make a complete cycle of 28 days. Palbociclib should be taken with or without food. Administer the recommended dosage of an aromatase inhibitor when given with Palbociclib. When given with Palbociclib, the recommended dose of fulvestrant is 500 mg administered on Days 1, 15, 29, and once monthly thereafter. Patients should be encouraged to take their dose of Palbociclib at approximately the same time each day.If the patient vomits or misses a dose, an additional dose should not be taken. The next prescribed dose should be taken at the usual time. Palbociclib capsules should be swallowed whole (do not chew, crush, or open them before swallowing). Palbociclib tablets should be swallowed whole (do not chew, crush, or split them before swallowing). Tablets/Capsules should not be ingested if they are broken, cracked, or otherwise not intact.
The most common side effects of Palbociclib are fatigue, neutropenia, diarrhea, infections, leukopenia, nausea, stomatitis, vomiting, anemia, alopecia, thrombocytopenia, rash, asthenia, pyrexia, and decreased appetite.
